Page last updated: 2024-11-07

hydroxysuccinimidyl-4-azidobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(4-azidobenzoyloxy)succinimide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122153
SCHEMBL ID13857013
MeSH IDM0094177

Synonyms (42)

Synonym
hsab
4-azidobenzoyloxysuccinimide
53053-08-0
nsc329704
nsc-329704
hydroxysuccinimidyl-4-azidobenzoate
(2,5-dioxopyrrolidin-1-yl) 4-azidobenzoate
hydroxysuccinimidyl-p-azidobenzoate
4-azidobenzoic acid n-hydroxysuccinimide ester
8zxq80nj3b ,
2,5-pyrrolidinedione, 1-((4-azidobenzoyl)oxy)-
n-hydroxysuccinimidyl-4-azidobenzoate
nsc 329704
unii-8zxq80nj3b
H1760
SCHEMBL13857013
4-azido-benzoic acid 2,5-dioxo-pyrrolidin-1-yl ester
A1-16319
DTXSID40201094
n-(4-azidobenzoyloxy)succinimide
AKOS025312399
3-hydroxy-2,5-dioxopyrrolidin-1-yl 4-azidobenzoate
CS-7064
n-hydroxysuccinimide 4-azidobenzoic ester
benzoic acid, 4-azido-, 2,5-dioxo-1-pyrrolidinyl ester
succinimidyl 4-azidobenzoate
LWAVGNJLLQSNNN-UHFFFAOYSA-N
mfcd00054963
4-azidobenzoic acid 2,5-dioxopyrrolidin-1-yl ester
n-hydroxysuccinimidyl-4-azidobenzoate;4-azidobenzoic acid n-hydroxysuccinimide ester
BCP33517
HY-126524
n3-ph-nhs ester
CS-0105083
n-hydroxysuccinimidyl-4-azidobenzoate [sab]
BP-24333
A917934
F82472
YSZCJ045
2,5-dioxopyrrolidin-1-yl 4-azidobenzoate
PD125929
n-hydroxysuccinimide 4-azidobenzoate

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Binding and covalent attachment of (125)I-labeled glucagon to the M(r) 53,000 peptide were inhibited by glucagon concentrations that were within the dose-response curve for adenylate cyclase activation, and GTP specifically decreased the photoaffinity crosslinking of (125)I-labeled glucagon to the M(r) 53,000 peptides."( Identification of the glucagon receptor in rat liver membranes by photoaffinity crosslinking.
Johnson, GL; MacAndrew, VI; Pilch, PF, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (64.44)18.7374
1990's10 (22.22)18.2507
2000's3 (6.67)29.6817
2010's1 (2.22)24.3611
2020's2 (4.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.90 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]